Global Pharmaceutical Blister Packaging Market Size To Exceed USD 46.15 Billion By 2035 | CAGR of 7.08%
Category: Advanced MaterialsGlobal Pharmaceutical Blister Packaging Market Size To Exceed USD 46.15 Billion By 2035 | CAGR of 7.08%
According to a research report published by Spherical Insights & Consulting, The Global Pharmaceutical Blister Packaging Market Size is Expected to grow from USD 21.75 Billion in 2024 to USD 46.15 Billion by 2035, at a CAGR of 7.08% during the forecast period 2025-2035.
Get more details on this report -
Browse key industry insights spread across 314 pages with 106 Market data tables and figures & charts from the report on the “Global Pharmaceutical Blister Packaging Market Size, Share, and COVID-19 Impact Analysis, By Material (Plastic, Aluminium Foil, and Paper), By Technology (Cold Forming, Thermoforming, and Heat Seal), By Application (Tablets, Capsules, Oral Thin Films & Lozenges, and Diagnostic Kits & Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 – 2035.” Get Detailed Report Description https://www.sphericalinsights.com/reports/pharmaceutical-blister-packaging-market
The pharmaceutical blister packaging market refers to the industry that emphasizes the production and supply of blister packs for pharmaceutical products. Pharmaceutical blister packaging is a type of healthcare packaging that protects the medicine from moisture and contamination and ensures safety. With the evolving consumer needs, the global market is transforming, driven by stringent regulatory requirements and packaging technology advancements aligning with eco-friendly packaging trends. Designing of hybrid boxes, which include blister packaging and additional compartments for drug delivery, such as inhalers, transdermal patches, and syringes, is escalating the market opportunities for pharmaceutical blister packaging. Introduction of sustainable & regulatory-compliant blister packaging solutions and cold-forming foil technology advancements are driving the pharmaceutical blister packaging market. Further, an increasing manufacturers' inclination towards solutions that provide protection against oxygen, moisture, and contaminants is anticipated to propel the market demand. On the contrary, the impact of economic slowdowns on pharmaceutical packaging investments, as well as the increasing rate of medical waste, are challenging the pharmaceutical blister packaging market.
The plastic segment dominated the market with the largest share in 2024 and is projected to grow at a substantial CAGR during the forecast period.
Based on the material, the pharmaceutical blister packaging market is divided into plastic, aluminium foil, and paper. Among these, the plastic segment dominated the market with the largest share in 2024 and is projected to grow at a substantial CAGR during the forecast period. Collaborative efforts on reducing single-use plastic packaging are contributing to driving the pharmaceutical blister packaging market.
The thermoforming segment accounted for the largest market share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period.
Based on the technology, the pharmaceutical blister packaging market is divided into cold forming, thermoforming, and heat seal. Among these, the thermoforming segment accounted for the largest market share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. Pharmaceutical companies use thermoforming as the most common and effective technology of pharmaceutical blister packaging due to faster production speed and lower manufacturing costs.
The tablets segment accounted for the largest market share in 2024 and is anticipated to grow at a significant CAGR during the forecast period.
Based on the application, the pharmaceutical blister packaging market is divided into tablets, capsules, oral thin films & lozenges, and diagnostic kits & others. Among these, the tablets segment accounted for the largest market share in 2024 and is anticipated to grow at a significant CAGR during the forecast period. Blister packaging is the commonly used unit dose packaging for pharmaceutical tablets, which provides barrier protection for shelf life requirements and a degree of tamper resistance.
North America is expected to hold the majority share of the global pharmaceutical blister packaging market during the forecast period.
Get more details on this report -
North America is expected to hold the majority share of the global pharmaceutical blister packaging market during the forecast period. An increasing use of blister packages, along with the growing sale of OTC drugs, is driving the market demand for pharmaceutical blister packaging. An increasing prevalence of diseases, as well as new product innovations including the use of sustainable materials, are contributing to promoting the pharmaceutical blister packaging market.
Asia Pacific is anticipated to grow at the fastest pace in the global pharmaceutical blister packaging market during the forecast period. The region’s expanding pharmaceutical sector, along with the increasing awareness about safe and effective drug packaging, is contributing to propelling the market. The upsurging need for maintaining product integrity and extended shelf life in the pharmaceutical sector is driving the market demand.
Major vendors in the global pharmaceutical blister packaging market are Amcor plc, Smurfit Westrock, Constantia Flexibles, Sonoco Products Company, Huhtamäki Oyj, Tekni-Plex Inc., ACG Pharmapack, Aptar CSP Technologies, Klöckner Pentaplast, Perlen Packaging, Honeywell International (Aclar Films), Bilcare Research, Bemis Healthcare (now Amcor Flexibles), Uhlmann Packaging Systems, IMA Group, Syntegon Technology, Marchesini Group, Romaco Group, PharmaWorks (ProMach), and Others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Key Market Development
- In November 2024, Switzerland-based Bayer launched polyethylene terephthalate (PET) blister packaging on its healthcare brand, Aleve, calling it a first-of-its-kind product in the healthcare industry.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the pharmaceutical blister packaging market based on the below-mentioned segments:
Global Pharmaceutical Blister Packaging Market, By Material
- Plastic
- Aluminium Foil
- Paper
Global Pharmaceutical Blister Packaging Market, By Technology
- Cold Forming
- Thermoforming
- Heat Seal
Global Pharmaceutical Blister Packaging Market, By Application
- Tablets
- Capsules
- Oral Thin Films & Lozenges
- Diagnostic Kits & Others
Global Pharmaceutical Blister Packaging Market, By Regional Analysis
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?